These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34298399)

  • 1. Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ.
    Švajger U; Tešić N; Rožman P
    Int Immunopharmacol; 2021 Oct; 99():107978. PubMed ID: 34298399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Effects of Interferon-γ and Vitamin D
    Švajger U; Rožman PJ
    Front Immunol; 2019; 10():2627. PubMed ID: 31798578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.
    Stephen-Victor E; Karnam A; Fontaine T; Beauvais A; Das M; Hegde P; Prakhar P; Holla S; Balaji KN; Kaveri SV; Latgé JP; Aimanianda V; Bayry J
    J Infect Dis; 2017 Dec; 216(10):1281-1294. PubMed ID: 28968869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
    Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
    mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.
    Dahlqvist G; Renaud S; Barjon C; Lefebvre A; Aoudjehane L; Horsmans Y; Delhem N; Conti F
    Immunobiology; 2021 Jan; 226(1):152031. PubMed ID: 33278711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
    Chattopadhyay G; Shevach EM
    J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD8
    Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
    Front Immunol; 2018; 9():2788. PubMed ID: 30555473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and the induction of tolerance by dendritic cells.
    Buckland M; Lombardi G
    Handb Exp Pharmacol; 2009; (188):197-213. PubMed ID: 19031027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.
    Kim YJ; Park SJ; Broxmeyer HE
    J Immunol; 2011 Sep; 187(5):2291-301. PubMed ID: 21795591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenteric lymph node CD11b
    Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
    Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.
    Wu C; Zhang Y; Jiang Y; Wang Q; Long Y; Wang C; Cao X; Chen G
    Cell Mol Immunol; 2013 Sep; 10(5):393-402. PubMed ID: 23872920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells.
    Mazerolles F; Rieux-Laucat F
    PLoS One; 2021; 16(11):e0260206. PubMed ID: 34793567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity of dendritic cells as a possible mechanism of negative regulation of T lymphocytes in pulmonary tuberculosis.
    Sakhno LV; Tikhonova MA; Tyrinova TV; Leplina OY; Shevela EY; Nikonov SD; Zhdanov OA; Ostanin AA; Chernykh ER
    Clin Dev Immunol; 2012; 2012():628635. PubMed ID: 23056139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.